🇺🇸 FDA

Intelligence · Clinical Pipeline

BRIGHT MINDS BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at BRIGHT MINDS BIOSCIENCES — phase, modality, and trial IDs.

Programs
1,063

Quick answer

BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Venlafaxine

    BRIGHT MINDS BIOSCIENCES INC.

    Depression

    phase 2 small molecule completed

    1 trial

  2. Venlafaxine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  3. Very Low Nicotine Content Cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence, Cigarettes, Uncomplicated

    phase 2 small molecule completed

    1 trial

  4. Very low nicotine content cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 other completed

    2 trials

  5. Very low nicotine content cigarettes

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    phase 2 small molecule completed

    2 trials

  6. Virtual Reality based distraction

    BRIGHT MINDS BIOSCIENCES INC.

    Pain

    phase 2 other completed

    1 trial

  7. WIDUS computer-delivered, indirect brief intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    phase 2 other completed

    1 trial

  8. Within-Subject test of blinded study medication

    BRIGHT MINDS BIOSCIENCES INC.

    Low Back Pain, Recurrent

    phase 2 small molecule completed

    1 trial

  9. Within-subject test of blinded study medications

    BRIGHT MINDS BIOSCIENCES INC.

    Pain

    phase 2 small molecule completed

    1 trial

  10. Workshop

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 other completed

    1 trial

  11. X-82

    BRIGHT MINDS BIOSCIENCES INC.

    Age-Related Macular Degeneration (AMD)

    phase 2 small molecule terminated

    1 trial

  12. YMSM

    BRIGHT MINDS BIOSCIENCES INC.

    Behavior

    phase 2 other completed

    1 trial

  13. aerobic exercise

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 other completed

    1 trial

  14. affect regulation training

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 other completed

    1 trial

  15. alprazolam

    BRIGHT MINDS BIOSCIENCES INC.

    Anxiety Disorder

    phase 2 small molecule completed

    1 trial

  16. atomoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 small molecule completed

    1 trial

  17. buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 2 small molecule active

    1 trial

  18. buprenorphine taper followed by naltrexone maintenance

    BRIGHT MINDS BIOSCIENCES INC.

    Prescription Opioid Dependence

    phase 2 small molecule completed

    1 trial

  19. chantix

    BRIGHT MINDS BIOSCIENCES INC.

    Varenicline and the Blunting of Cocaine Cues

    phase 2 small molecule terminated

    1 trial

  20. chatbot

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-Related Disorders

    phase 2 other active

    1 trial

  21. citicoline

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 2 small molecule completed

    1 trial

  22. clarithromycin

    BRIGHT MINDS BIOSCIENCES INC.

    Relapse/Refractory Multiple Myeloma

    phase 2 small molecule terminated

    1 trial

  23. coformulated emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF) as PrEP

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 small molecule completed

    1 trial

  24. controlled release carvedilol

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  25. d-cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    Panic Disorder

    phase 2 small molecule completed

    1 trial

  26. d-cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    COCAINE-RELATED DISORDERS

    phase 2 small molecule completed

    1 trial

  27. dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 2 small molecule completed

    1 trial

  28. e-cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Nontherapeutic

    phase 2 other completed

    1 trial

  29. employment-based reinforcement

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 2 other completed

    1 trial

  30. empowerment theory-based small group discussion

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    phase 2 other completed

    1 trial

  31. extended-release buprenorphine (BXR)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 2 small molecule on hold

    1 trial

  32. guanfacine-ER

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use

    phase 2 small molecule completed

    1 trial

  33. l-tetrahydropalmatine (l-THP)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use

    phase 2 small molecule terminated

    1 trial

  34. levetiracetam

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    2 trials

  35. levodopa

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  36. lorcaserin

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

  37. metformin

    BRIGHT MINDS BIOSCIENCES INC.

    Type 2 Diabetes

    phase 2 small molecule active

    1 trial

  38. mirtazapine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 small molecule completed

    1 trial

  39. naltrexone implant

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 2 small molecule active

    2 trials

  40. nicotine transdermal system

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 small molecule completed

    1 trial

  41. opiates

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 2 small molecule completed

    1 trial

  42. oxycodone 15 mg

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 2 small molecule completed

    1 trial

  43. placebo mouthwash

    BRIGHT MINDS BIOSCIENCES INC.

    Dentinal Hypersensitivity

    phase 2 other completed

    1 trial

  44. sunitinib added to FOLFIRI

    BRIGHT MINDS BIOSCIENCES INC.

    Metastatic Colorectal Cancer

    phase 2 small molecule completed

    1 trial

  45. telephone based skills training intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 other completed

    1 trial

  46. topiramate

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  47. tramadol

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Abuse

    phase 2 small molecule completed

    1 trial

  48. transdermal nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does BRIGHT MINDS BIOSCIENCES have?

1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.